REGN icon

Regeneron Pharmaceuticals

670 hedge funds and large institutions have $27.1B invested in Regeneron Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 226 increasing their positions, 222 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

0.53% less ownership

Funds ownership: 69.48%68.96% (-0.53%)

9% less capital invested

Capital invested by funds: $29.8B → $27.1B (-$2.65B)

24% less call options, than puts

Call options by funds: $755M | Put options by funds: $994M

Holders
670
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$755M
Puts
$994M
Net Calls
Net Calls Change

Top Buyers

1 +$241M
2 +$124M
3 +$87.4M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$63M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$58.6M

Top Sellers

1 -$399M
2 -$226M
3 -$78.8M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$69.1M
5
O
OrbiMed
New York
-$64.4M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.63B
2
$2.21B
3
$2.2B
4
$2B
5
$1.22B
6
$1.18B
7
$1.12B
8
$1.12B
9
$777M
10
$571M
11
$555M
12
$470M
13
$466M
14
$460M
15
$402M
16
$375M
17
$356M
18
$350M
19
$347M
20
$328M
21
$292M
22
$254M
23
$242M
24
$226M
25
$221M